SALT LAKE CITY, March 12, 2012 /PRNewswire/ -- Dynatronics Corporation (NASDAQ: DYNT) today announced the introduction of the new Dynatron Quad7 therapy device. The innovative Quad7 redefines cold/compression therapy in the sports medicine and physical therapy markets by adding options for heat therapy as well as facilitating thermal therapy in combination with electrical stimulation through the use of proprietary combination probes. The Quad7 has the flexibility to offer seven different treatments – leapfrogging current technologies and products in the market. "We are beginning to enjoy the first fruits of our extensive R&D efforts," stated Kelvyn H. Cullimore Jr., chairman and president of Dynatronics. "The new Quad7 is the first of several new products scheduled for release in 2012. In fact, we now have more new products scheduled for introduction in 2012 than during any year in the company's history. This commitment to R&D further strengthens Dynatronics' long-standing reputation as an innovator and market leader in the development of physical rehab equipment." The Quad7 delivers therapy treatment through a variety of wraps and innovative ThermoStim Probes. "The addition of manual probes to the package will allow delivery of electrical stimulation, combined with either heat or cold to localized areas," reported Larry K. Beardall, executive vice president of sales and marketing. "This dramatically expands both the variety and location of conditions that can be treated, thus making current delivery methods even more obsolete." The Dynatron Quad7 uses thermoelectric technology to provide precise temperature control, eliminating the need for ice. "No ice is nice," said Beardall. "Clinicians will love eliminating the hassle and mess of melting ice cubes." The economic downturn over the past few years has diminished new product development in the physical medicine market. "Our markets are starving for innovative new products. We're thrilled to be in a position to deliver them," added Beardall. "Product availability will be limited in these first few months as we ramp up production, but that should just add to the demand for this unique new device."